Launch of Hyde Park Discovery between UChicago, Deerfield Management to accelerate research into life-saving treatments ...

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

A high-resolution spatial map of the human hypothalamus makes it possible to identify specific cells, determine their exact ...

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

Wen Shuhao helped speed up the development of Pfizer’s Covid oral drug, Paxlovid. Now the chairman of Xtalpi wants to help ...

Now, Scripps Research scientists have uncovered new ... This discovery could also contribute to the development of new drugs for ATTR. "We've unveiled a molecular complexity that has been hidden ...

II-73, has the potential to restore memory and cognitive function in a mouse model of Alzheimer's disease. The study demonstrates that the drug improves memory deficits and reverses brain cell damage, ...

Despite high demand for an option like Journavx, doctors fear the drug’s price could be a hangup for insurers and limit ...

the company that developed the new drug. The FDA's sign-off on the medication comes as the agency says it is prioritizing supporting the development of non-opioid pain treatment. Suzetrigine is ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

As one of the largest tuberculosis outbreaks in the U.S. unfolds in Kansas, UC San Diego researchers and their colleagues ...